Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus
We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.
Gespeichert in:
Veröffentlicht in: | European journal of obstetrics & gynecology and reproductive biology 1998-08, Vol.79 (2), p.227-229 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 229 |
---|---|
container_issue | 2 |
container_start_page | 227 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 79 |
creator | Somerset, David A Raine-Fenning, Nicholas Gordon, Caroline Weaver, Judith B Kilby, Mark D |
description | We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus. |
doi_str_mv | 10.1016/S0301-2115(98)00070-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73853800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211598000700</els_id><sourcerecordid>73853800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi0EKtvCI1TKASF6CNhxvHZOqKr4U6kSB-BsOfaka5TYweMU7Svw1Di7q71ysGzN_GY-zzeEXDP6nlG2_fCdcsrqhjHxrlM3lFJJa_qMbJiSTS23on1ONmfkJblE_FUgynl3QS462VDVqg35ex9yMk8Q4oKVn6YlxMcx9svoQ5V3kMy8r8rTxmlOcfIIrpoTPAYTrAesDGK03uQS_uPzrjIh-3kXsZzRz94dAn10Bza4CveYYfK2Gpe5CELaF5HJ5IgLviIvBjMivD7dV-Tn508_7r7WD9--3N_dPtSWqy7XzljOwAomoHVSDLw1HTWOd1Y2DR06LtptLymFwW1BNAravneD5QODQQpF-RV5e-xbJvq9AGZd5rIwjiZAcUFLrgRXdAXFEbQpIiYY9Jz8ZNJeM6rXHejDDvRqsO6UPuxAr3XXJ4Gln8Cdq06ml_ybU96gNeOQVjPxjDVN1wouC_bxiEEx48lD0lg8DxacT2CzdtH_5yP_ABZqqIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73853800</pqid></control><display><type>article</type><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</creator><creatorcontrib>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</creatorcontrib><description>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/S0301-2115(98)00070-0</identifier><identifier>PMID: 9720848</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Antiphospholipid syndrome ; Antiphospholipid Syndrome - therapy ; Biological and medical sciences ; Female ; Fetal compromise ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunomodulators ; Intravenous immunoglobulin ; Lupus Erythematosus, Systemic - therapy ; Medical sciences ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Complications - therapy ; Systemic lupus erythematosus</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 1998-08, Vol.79 (2), p.227-229</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</citedby><cites>FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0301-2115(98)00070-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2294537$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9720848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Somerset, David A</creatorcontrib><creatorcontrib>Raine-Fenning, Nicholas</creatorcontrib><creatorcontrib>Gordon, Caroline</creatorcontrib><creatorcontrib>Weaver, Judith B</creatorcontrib><creatorcontrib>Kilby, Mark D</creatorcontrib><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</description><subject>Adult</subject><subject>Antiphospholipid syndrome</subject><subject>Antiphospholipid Syndrome - therapy</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Fetal compromise</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunomodulators</subject><subject>Intravenous immunoglobulin</subject><subject>Lupus Erythematosus, Systemic - therapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - therapy</subject><subject>Systemic lupus erythematosus</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi0EKtvCI1TKASF6CNhxvHZOqKr4U6kSB-BsOfaka5TYweMU7Svw1Di7q71ysGzN_GY-zzeEXDP6nlG2_fCdcsrqhjHxrlM3lFJJa_qMbJiSTS23on1ONmfkJblE_FUgynl3QS462VDVqg35ex9yMk8Q4oKVn6YlxMcx9svoQ5V3kMy8r8rTxmlOcfIIrpoTPAYTrAesDGK03uQS_uPzrjIh-3kXsZzRz94dAn10Bza4CveYYfK2Gpe5CELaF5HJ5IgLviIvBjMivD7dV-Tn508_7r7WD9--3N_dPtSWqy7XzljOwAomoHVSDLw1HTWOd1Y2DR06LtptLymFwW1BNAravneD5QODQQpF-RV5e-xbJvq9AGZd5rIwjiZAcUFLrgRXdAXFEbQpIiYY9Jz8ZNJeM6rXHejDDvRqsO6UPuxAr3XXJ4Gln8Cdq06ml_ybU96gNeOQVjPxjDVN1wouC_bxiEEx48lD0lg8DxacT2CzdtH_5yP_ABZqqIA</recordid><startdate>19980801</startdate><enddate>19980801</enddate><creator>Somerset, David A</creator><creator>Raine-Fenning, Nicholas</creator><creator>Gordon, Caroline</creator><creator>Weaver, Judith B</creator><creator>Kilby, Mark D</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980801</creationdate><title>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</title><author>Somerset, David A ; Raine-Fenning, Nicholas ; Gordon, Caroline ; Weaver, Judith B ; Kilby, Mark D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-dac31ec515e4d75f34a90ad39c7220f93546b700efd6e528e4bbdfc3f1ef75803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Antiphospholipid syndrome</topic><topic>Antiphospholipid Syndrome - therapy</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Fetal compromise</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunomodulators</topic><topic>Intravenous immunoglobulin</topic><topic>Lupus Erythematosus, Systemic - therapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - therapy</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Somerset, David A</creatorcontrib><creatorcontrib>Raine-Fenning, Nicholas</creatorcontrib><creatorcontrib>Gordon, Caroline</creatorcontrib><creatorcontrib>Weaver, Judith B</creatorcontrib><creatorcontrib>Kilby, Mark D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Somerset, David A</au><au>Raine-Fenning, Nicholas</au><au>Gordon, Caroline</au><au>Weaver, Judith B</au><au>Kilby, Mark D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>1998-08-01</date><risdate>1998</risdate><volume>79</volume><issue>2</issue><spage>227</spage><epage>229</epage><pages>227-229</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>We report two successful outcomes following intravenous immunoglobulin therapy as adjunctive treatment in severely compromised, growth restricted pregnancies associated with antiphospholipid syndrome and systemic lupus erythematosus.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9720848</pmid><doi>10.1016/S0301-2115(98)00070-0</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 1998-08, Vol.79 (2), p.227-229 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_73853800 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Antiphospholipid syndrome Antiphospholipid Syndrome - therapy Biological and medical sciences Female Fetal compromise Humans Immunoglobulins, Intravenous - therapeutic use Immunomodulators Intravenous immunoglobulin Lupus Erythematosus, Systemic - therapy Medical sciences Pharmacology. Drug treatments Pregnancy Pregnancy Complications - therapy Systemic lupus erythematosus |
title | Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A45%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin%20therapy%20in%20compromised%20pregnancies%20associated%20with%20antiphospholipid%20antibodies%20and%20systemic%20lupus%20erythematosus&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Somerset,%20David%20A&rft.date=1998-08-01&rft.volume=79&rft.issue=2&rft.spage=227&rft.epage=229&rft.pages=227-229&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/S0301-2115(98)00070-0&rft_dat=%3Cproquest_cross%3E73853800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73853800&rft_id=info:pmid/9720848&rft_els_id=S0301211598000700&rfr_iscdi=true |